AUSTIN, Texas, Nov. 3, 2025 /PRNewswire/ -- Ambetter from Superior HealthPlan and Ambetter Health, products offered by Centene Corporation (NYSE: CNC), a leading healthcare enterprise that provides insurance to under-insured and uninsured populations through the Health Insurance Marketplace®, will offer a variety of affordable health insurance plans to Texas residents in 150 counties for plan year 2026. The open enrollment period for the Health Insurance Marketplace runs from Nov. 1, 2025, through Jan. 15, 2026. Enroll by Dec. 15, 2025, for coverage starting Jan. 1, 2026.
"For more than a decade, Texans have had access to quality and affordable health insurance through Ambetter Health," said Plan President and Chief Executive Officer of Superior HealthPlan, Mitch Wasden. "In 2026, we are confident the variety of healthcare programs we're offering are going to meet the needs of all those we serve."
Ambetter Health offers its members access to quality care and convenient services. 2026 benefits and offerings include:
To support members through the 2026 renewal process and beyond, Ambetter Health is offering a range of tools and programs designed to make coverage easier to understand and maintain. These include Member Advisory Group meetings, a mobile application, member portal and digital support tools such as Wellframe.
The full list of 150 counties in which Ambetter from Superior HealthPlan will be offered can be found at ambetterhealth.com/en/tx/health-plans/coverage-map.
Texas residents interested in learning more about Ambetter Health or enrolling in a health plan during the open enrollment period may visit ambetterhealth.com/en/tx.
About Ambetter from Superior HealthPlan
Ambetter from Superior HealthPlan serves under-insured and uninsured populations through the federal Health Insurance Marketplace®. Ambetter from Superior HealthPlan includes exclusive provider organization (EPO) products that are underwritten by Celtic Insurance Company and HMO products that are underwritten by Superior HealthPlan, Inc. These companies are each Qualified Health Plan issuers in the Texas Health Insurance Marketplace. Ambetter Health includes HMO products that are underwritten by Ambetter Health of Texas, Inc. This is a solicitation for insurance. For information on your right to receive an Ambetter Health plan free of discrimination, or your right to receive language, auditory and/or visual assistance services, please visit ambetterhealth.com/en/ and scroll to the bottom of the page.
*Healthcare-related costs will vary by member and the plan in which you are enrolled. Funds expire immediately upon termination of insurance coverage. My Health Pays® rewards cannot be used for pharmacy copays. Restrictions apply. Members must qualify for and complete all activities to receive $500 or more. Visit Member.AmbetterHealth.com for more details. Your health plan is committed to helping you achieve your best health. Rewards for participating in a wellness program are available to all members. If you think you might be unable to meet a standard for a reward under this wellness program, you might qualify for an opportunity to earn the same reward by different means. Contact us at 1-877-687-1196 (Relay Texas/TTY 1-800-735-2989) and we will work with you (and, if you wish, with your doctor) to find a wellness program with the same reward that is right for you in light of your health status.
**Cost sharing may apply when using Virtual 24/7 Care or Virtual Primary Care. Virtual 24/7 Care cost share does not apply to HSA plans until the deductible is met and is only applicable when used through the Virtual 24/7 Care program. Ambetter Health does not provide medical care. Medical care is provided by individual providers, which are independent contractors and not agents of Ambetter Health.

| Last Trade: | US$34.14 |
| Daily Change: | -1.23 -3.48 |
| Daily Volume: | 5,029,621 |
| Market Cap: | US$16.780B |
October 29, 2025 July 29, 2025 July 25, 2025 April 25, 2025 | |

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load